Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial - The Lancet Get link Facebook X Pinterest Email Other Apps March 20, 2020 Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial The Lancet Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment